NCT03116997View on ClinicalTrials.gov

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 7, 2017

Primary Completion Date

March 3, 2022

Study Completion Date

March 3, 2022

Conditions
Surgery
Interventions
DRUG

Neostigmine+glycopyrrolate

At the conclusion of surgery neuromuscular blockade reversed with neostigmine/glycopyrrolate

DRUG

Sugammadex

At the conclusion of surgery neuromuscular blockade reversed with sugammadex

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memoral Sloan Kettering Westchester, Harrison

11725

Memorial Sloan Kettering Commack, Commack

07920

Memoral Sloan Kettering Basking Ridge, Basking Ridge

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03116997 - Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant | Biotech Hunter | Biotech Hunter